TWD 361.5
(-0.14%)
Year | Eps | Eps Growth |
---|---|---|
2023 | 22.83 TWD | 4.97% |
2022 | 21.75 TWD | 23.51% |
2021 | 17.61 TWD | 74.53% |
2020 | 10.09 TWD | 34.18% |
2019 | 7.52 TWD | -15.51% |
2018 | 8.90 TWD | 78.36% |
2017 | 4.99 TWD | 62.54% |
2016 | 3.07 TWD | 46.89% |
2015 | 2.09 TWD | 64.57% |
2014 | 1.27 TWD | 20.95% |
2013 | 1.05 TWD | 184.0% |
2012 | -1.25 TWD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q1 | 7.10 TWD | -3.4% |
2024 Q2 | 6.09 TWD | -14.23% |
2024 Q3 | 5.61 TWD | -7.88% |
2023 Q1 | 4.77 TWD | -19.29% |
2023 Q3 | 5.24 TWD | 1.55% |
2023 Q2 | 5.16 TWD | 8.18% |
2023 Q4 | 7.35 TWD | 40.27% |
2023 FY | - TWD | 4.97% |
2022 Q4 | 5.91 TWD | -1.83% |
2022 Q2 | 4.87 TWD | -4.88% |
2022 FY | - TWD | 23.51% |
2022 Q1 | 5.12 TWD | -2.29% |
2022 Q3 | 6.02 TWD | 23.61% |
2021 Q1 | 3.17 TWD | -21.14% |
2021 FY | - TWD | 74.53% |
2021 Q4 | 5.24 TWD | 2.95% |
2021 Q3 | 5.09 TWD | 22.06% |
2021 Q2 | 4.17 TWD | 31.55% |
2020 Q2 | 1.97 TWD | 53.91% |
2020 FY | - TWD | 34.18% |
2020 Q3 | 2.86 TWD | 45.18% |
2020 Q1 | 1.28 TWD | -56.61% |
2020 Q4 | 4.02 TWD | 40.56% |
2019 Q3 | 1.77 TWD | 23.78% |
2019 Q2 | 1.43 TWD | -15.88% |
2019 Q1 | 1.70 TWD | -32.54% |
2019 FY | - TWD | -15.51% |
2019 Q4 | 2.95 TWD | 66.67% |
2018 Q4 | 2.52 TWD | -14.86% |
2018 FY | - TWD | 78.36% |
2018 Q3 | 2.96 TWD | 49.49% |
2018 Q2 | 1.98 TWD | 13.79% |
2018 Q1 | 1.74 TWD | 24.29% |
2017 Q3 | 1.40 TWD | 26.13% |
2017 Q1 | 1.11 TWD | 18.09% |
2017 FY | - TWD | 62.54% |
2017 Q4 | 1.40 TWD | 0.0% |
2017 Q2 | 1.11 TWD | 0.0% |
2016 Q1 | 0.61 TWD | 5.17% |
2016 Q2 | 0.61 TWD | 0.0% |
2016 Q3 | 0.94 TWD | 54.1% |
2016 FY | - TWD | 46.89% |
2016 Q4 | 0.94 TWD | 0.0% |
2015 Q4 | 0.58 TWD | 0.0% |
2015 Q2 | 0.48 TWD | 0.0% |
2015 Q3 | 0.58 TWD | 20.83% |
2015 Q1 | 0.48 TWD | 2.13% |
2015 FY | - TWD | 64.57% |
2014 Q2 | 0.13 TWD | -18.75% |
2014 Q3 | 0.47 TWD | 261.54% |
2014 FY | - TWD | 20.95% |
2014 Q4 | 0.47 TWD | 0.0% |
2014 Q1 | 0.16 TWD | -15.79% |
2013 Q2 | 0.34 TWD | 0.0% |
2013 Q4 | 0.19 TWD | 0.0% |
2013 Q1 | 0.34 TWD | 0.0% |
2013 FY | - TWD | 184.0% |
2013 Q3 | 0.19 TWD | -44.12% |
2012 FY | - TWD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Nang Kuang Pharmaceutical Co., Ltd. | 1.96 TWD | -1064.796% |
Maxigen Biotech Inc. | 1.86 TWD | -1127.419% |
SciVision Biotech Inc. | 2.66 TWD | -758.271% |
Bionime Corporation | 0.10 TWD | -22730.0% |
Visco Vision Inc. | 4.79 TWD | -376.618% |